NIFTY NINE IN NINETY NINE PLUS ONE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (101)	1/8/1999 3:47:00 AM
From: Mike McFarland	of 613

...fyi I'd had CTIC on my watchlist for most of the fall. I watched it, mainly because they're here in Seattle probably and the water soluble taxol must have been in the news or something...oh and I saw a report from Lehman which gave a list of biotechs where were at book--I think at the time ctic was at $2. Anyway, I watched this for awhile, let it run up the buck and didn't worry about jumping on...but then that anti angiogenesis blurb they put out finally caught my eye again. biz.yahoo.com this is an unusually well written PR and I recommend anybody interested in anti-angio read it--even if you were just a spectator to the Entremed rocket last spring. --MM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next